| Literature DB >> 26369784 |
Huaiwu He1, Yun Long2, Dawei Liu3, Xiaoting Wang4, Xiang Zhou5.
Abstract
INTRODUCTION: We investigated whether combining the peripheral perfusion index (PI) and central venous oxygen saturation(ScvO2) would identify subsets of patients for assessing the tissue perfusion and predicting outcome during the resuscitation in critically ill patients.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26369784 PMCID: PMC4568576 DOI: 10.1186/s13054-015-1057-8
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Characteristics of the patients
| Number of patients | 202 |
| Age, years | 57 ± 18 |
| Sex, n, female/male | 104/98 |
| Baseline PaO2, mmHg | 142 ± 72 |
| Baseline Hb, g/dl | 11 ± 3 |
| Admission ward | |
| Medical | 15 |
| Surgical | 146 |
| Emergency | 42 |
| Admission category | |
| Sepsis | 84 |
| Postoperative with high risk | 96 |
| Other | 22 |
| Baseline APACHE II score | 13 (9–20) |
| Baseline SOFA score | 8 (5–10) |
| Baseline mechanical ventilation, % (n/total) | 85 % (171/202) |
| Baseline NE, % (n/total) | 37 % (75/202) |
| Baseline NE dose, ug/kg/min | 0.11 ± 0.23 |
| NE, % (n/total) at T8 | 48 % (96/202) |
| NE dose at T8, ug/kg/min | 0.22 ± 0.63 |
| ICU LOS, days | 6 ± 10 |
| Survivor/non-survivor at 30 days n/total (%) | 28/202 (14 %) |
Results are presented as mean ± SD or median (IQR) unless stated otherwise
Hb hemoglobin concentration, PaO arterial oxygen tension, APACHE acute physiology and chronic health evaluation, SOFA sequential organ failure assessment score, LOS length of stay, NE norepinephrine
Fig. 1Flow diagram showing the 202 patients stratified according to central venous oxygen saturation (ScvO ) and peripheral perfusion index (PI) at 8 h after resuscitation (T8). pts patients, T0 baseline
Receiver operating characteristic (ROC) curve analysis of the different variables at 8 h (T8) to predict mortality at 30 days
| Variable | ROC area | 95 % CI | Cutoff value | Sensitivity | Specificity |
|---|---|---|---|---|---|
| Lactate, mmol/L | 0.693* | 0.625, 0.756 | 3.6 | 35.71 | 94.83 |
| ScvO2, % | 0.669* | 0.599, 0.733 | 70 | 42.86 | 83.33 |
| P(v-a) CO2 | 0.596* | 0.525, 0.664 | 6 | 42.86 | 70.11 |
| PI | 0.835 | 0.777, 0.884 | 0.6 | 60.71 | 89.66 |
P(v-a)CO , difference between central venous and arterial PCO2 (mmHg), PI peripheral perfusion index measured by pulse oximetry, ScvO central venous O2 saturation
*P <0.05 for comparison of PI vs ScvO2, P(v-a) CO2, and lactate
Fig. 2Receiver operating characteristic curves comparing the ability of peripheral perfusion index (PI), lactate (Lac), difference between central venous and arterial PCO2 (Pv-a CO ) and central venous O2 saturation (ScvO ) to discriminate mortality at day 30 in all the critically ill patients. AUC area under the curve
Fig. 3Survival probabilities up to day 30 according to central venous O2 saturation (ScvO2) and peripheral perfusion index (PI) after 8 h of resuscitation. Log rank (Mantel–Cox) = 87.518, p <0.0001. Group 1 (PI ≤0.6 with ScvO2 < 70 %); group 2 (PI ≤0.6 with ScvO2 ≥ 70 %); group 3 (PI >0.6 with ScvO2 < 70 %); and group 4 (PI >0.6 with ScvO2 ≥ 70 %). Cum survival cumulative survival
Fig. 4Mortality at day 30 for predefined groups based on PI(0.6) and ScvO2(70 %) at T8 after resuscitation. *p < 0.05. ns, no significance. group 1 (PI ≤ 0.6 with ScvO2 < 70 %); group 2 (PI ≤ 0.6 with ScvO2 ≥ 70 %); group 3 (PI > 0.6 with ScvO2 < 70 %); and group 4 (PI > 0.6 with ScvO2 ≥ 70 %)
Related variables and outcome of different groups according to ScvO2 level at 8 h (T8) after resuscitation
| Low ScvO2 < 70 % | Normal 70 ≤ ScvO2 ≤ 80 | High ScvO2 > 80 % | |
|---|---|---|---|
|
|
|
| |
| P(v-a) CO2 at T8 | 8 ± 4*,** | 6 ± 3** | 5 ± 4 |
| Lactate at T8, mmol/L | 2.9 ± 3.8 | 1.9 ± 1.8 | 1.7 ± 1.7 |
| 8-h LC, % | 13 (−3 to 50) | 26 (1 to 50) | 40 (1 to 57) |
| PI at T8 | 1.9 ± 1.7** | 2.0 ± 1.3** | 2.5 ± 1.6 |
| Patients, n/total (%), PI ≤0.6 at T8 | 10/35 (29 %) | 15/90 (17 %) | 10/77 (13 %) |
| Mortality at day 30, n/total (%) | 10/35 (29 %) | 13/90 (14 %) | 5/77 (6 %) |
Results are presented as mean ± SD or median (IQR) unless stated otherwise
ScvO central venous oxygen saturation (%), P(v-a) CO veno-arterial CO2 tension difference (mmHg), PI peripheral perfusion index, LC lactate clearance
*P <0.05 for comparison to normal
**p <0.05 for comparison to high
Multivariate logistic regression for predictors of 30-day mortality at baseline (T0) and 8 h (T8)
| Variables | T0 | T8 | ||||
|---|---|---|---|---|---|---|
| RR | 95 % CI |
| RR | 95 % CI |
| |
| PI | 1.055 | 0.685, 1.691 | 0.825 | 2.439 | 1.296, 4.589 | 0.006 |
| Lactate | 1.118 | 0.868, 1.439 | 0.388 | 1.228 | 0.886, 1.702 | 0.218 |
| ScvO2,% | 0.990 | 0.936, 1.046 | 0.710 | 1.080 | 1.007, 1.158 | 0.032 |
| P(v-a)CO2, mmHg | 0.981 | 0.866, 1.112 | 0.767 | 0.975 | 0.828, 1.148 | 0.763 |
| HR | 0.936 | 0.909, 0.965 | 0.000 | 0.964 | 0.939, 0.991 | 0.008 |
| CVP | 0.922 | 0.792, 1.074 | 0.298 | 1.059 | 0.890, 1.259 | 0.519 |
| MAP | 1.016 | 0. 983, 1.051 | 0.333 | 1.017 | 0.975, 1.060 | 0.434 |
| Age, years | 0.968 | 0.935, 1.002 | 0.068 | 0.998 | 0.967, 1.030 | 0.899 |
| Gender | 0.496 | 0.172, 1.434 | 0.196 | 0.396 | 0.128, 1.224 | 0.108 |
| NE dose, ug/kg/min | 0.146 | 0.022, 0.969 | 0.046 | 0.103 | 0.015, 0.692 | 0.019 |
CVP central venous pressure, MAP mean arterial pressure, HR heart rate, ScvO2 central venous oxygen saturation, P(v-a) CO2 difference in venoarterial CO2 tension, NE norepinephrine, PI peripheral perfusion index
Related variables and outcome in different groups according to stratification by severity of impairment of PI at T8 after normalization of ScvO2 (≥70 %)
| Critical | Mild | Normal | ||
|---|---|---|---|---|
| PI ≤0.6 | 0.6 < PI <1.4 | PI ≥1.4 | ||
|
|
|
| ||
| T0 | CVP, mmHg | 9 ± 4 | 9 ± 3 | 10 ± 3 |
| MAP | 94 ± 20 | 90 ± 16 | 91 ± 17 | |
| ScvO2, % | 71 ± 13 | 74 ± 11 | 77 ± 9 | |
| P(v-a) CO2, mmHg | 8 ± 4** | 6 ± 4 | 6 ± 3 | |
| Lactate, mmol/L | 3.2 ± 3.1 | 2.6 ± 1.8 | 2.8 ± 2.2 | |
| PI | 0.6 ± 0.6*,** | 0.9 ± 0.6** | 1.8 ± 1.3 | |
| T8 | CVP, mmHg | 9 ± 4 | 9 ± 3 | 8 ± 3 |
| MAP | 87 ± 15 | 88 ± 10 | 86 ± 13 | |
| ScvO2, % | 80 ± 4 | 79 ± 6 | 80 ± 6 | |
| P(v-a) CO2, mmHg | 7 ± 5 | 5 ± 3 | 5 ± 3 | |
| Lactate, mmol/L | 2.9 ± 3.2** | 1.8 ± 1.4 | 1.5 ± 1.2 | |
| PI | 0.4 ± 0.2*,** | 1 ± 0.2** | 3.1 ± 1.2 | |
| Base APACHE II | 20 (12 to 29)* | 11 (8 to 21) | 12 (7 to 16) | |
| Base SOFA | 9 (7 to 10)** | 7 (5 to 11) | 7 (4 to 9) | |
| Mortality at day 30, n/total (%) | 9/25 (35 %)*,** | 4/37 (11 %) | 5/105 (5 %) | |
| 8-h LC, % | 14 (−45 to 38)** | 25 (−2.5 to 47) | 43 (0 to 60) | |
Results are presented as mean ± SD or median (IQR) unless stated otherwise
APACHE acute physiology and chronic health evaluation, SOFA sequential organ failure assessment score, CVP central venous pressure, MAP mean arterial pressure, ScvO central venous oxygen saturation, P(v-a) CO veno-arterial CO2 tension difference, PI peripheral perfusion index, LC lactate clearance
*P <0.05 for comparison to mild-moderate
**p <0.05 compared to normal
Fig. 5Mortality at day 30 according to stratification by severity of impairment of peripheral perfusion index (PI) after normalization of central venous oxygen saturation (ScvO2) (≥70 %) at 8 h (T8). *P <0.05; ns not significant. PI ≥1.4 (normal PI, n = 105); 0.6 < PI <1.4 (PI mild impairment n = 37); PI ≤0.6 (PI critical impairment, n = 25)